Back to Tirzepatide research
tirzepatide gip agonist cohort 2025-01-31 ClinicalTrials

Real-World Observational Study to Track Anti-Obesity Medication Effects

Study of Patients Being Treated With Anti-obesity Medication

Background

The global prevalence of obesity and overweight conditions continues to rise, necessitating effective and sustainable medical weight management strategies, often involving anti-obesity medications. While initial clinical trials demonstrate drug efficacy, there remains a critical need to understand the long-term, real-world effectiveness and comprehensive patient experiences when these medications are used in routine clinical practice. This ongoing observational study aims to address this knowledge gap by closely monitoring adults receiving such treatments.


tirzepatide gip agonist glp 1 agonist protocol relevant
Source: clinicaltrials:NCT06790160 · Ingested 2026-04-03 · Digest: gemini-2.5-flash